CN Patent

CN111592546B — 奥德司他的制备方法

Assigned to Shanghai Kunbo Jiurui Pharmaceutical Technology Development Co ltd · Expires 2023-08-25 · 3y expired

What this patent protects

本发明揭示了一种奥德司他(Osilodrostat)的制备方法。该方法以4‑[(1R)‑1‑氨基‑2‑羟基乙基]‑3‑氟‑苯腈为原料，依次经过环合、氧化、溴代、维蒂希和催化氢化等基本单元反应，生成目标产物奥德司他。该制备方法工艺简洁，条件温和，安全环保，为的工业化生产提供了一条新合成途径。

USPTO Abstract

本发明揭示了一种奥德司他(Osilodrostat)的制备方法。该方法以4‑[(1R)‑1‑氨基‑2‑羟基乙基]‑3‑氟‑苯腈为原料，依次经过环合、氧化、溴代、维蒂希和催化氢化等基本单元反应，生成目标产物奥德司他。该制备方法工艺简洁，条件温和，安全环保，为的工业化生产提供了一条新合成途径。

Drugs covered by this patent

Patent Metadata

Patent number
CN111592546B
Jurisdiction
CN
Classification
—
Expires
2023-08-25
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Kunbo Jiurui Pharmaceutical Technology Development Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.